Affymetrix - Thermo Fisher Scientific

QIAGEN’s Liquid Biopsy Portfolio – from Sample to Insight

Qiagen

Optimal cell growth starts with NutriStem hPSC Medium

Biological Industries

SISCAPA Licenses Liquid Chromatography/Mass Spectrometry Assay Technology to Waters Corporation

SISCAPA Assay Technologies announces Waters Corporation has obtained license to technology from SAT for the standardization of liquid chromatography/mass spectrometry assays.

Candidate Metabolomic Network for Bladder Cancer Diagnostics Identified

numares AG obtained promising results from a retrospective study that provides initial evidence that evaluation of metabolomic biomarker networks can be used as a non-invasive diagnostic for bladder cancer.

Benefits of Droplet Digital PCR to Measure Immunotherapy Response Highlighted at ASCO Annual Meeting

New research demonstrating the clinical potential of Droplet Digital PCR technology to measure patient response to immunotherapy was presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in June.

Owlstone Medical, Cancer Research UK Initiate Pan Cancer Clinical Trial to Evaluate Breath Biopsy for Early Detection of Disease

Owlstone Medical and Cancer Research UK begin trial to improve the speed of detection and diagnosis of multiple cancer types.